The Effect of SV 293, a D2 Dopamine Receptor-Selective Antagonist, on D2 Receptor-Mediated GIRK Channel Activation and Adenylyl Cyclase Inhibition

By  

Pharmacology, Vol. 92, Iss. 1-2, 2013-08 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia

By Oda Yasunori   Kanahara Nobuhisa   Iyo Masaomi  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 30144-30163

MDPI

Access to resources Recommend Favorite

Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways

By Lien Li-Ming   Lin Kuan-Hung   Huang Li-Ting   Tseng Mei-Fang   Chiu Hou-Chang   Chen Ray-Jade   Lu Wan-Jung  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1500-1500

MDPI

Access to resources Recommend Favorite

The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis

By Cui Yin   Prabhu Vishwanath   Nguyen Thong Ba   Yadav Binod Kumar   Chung Young-Chul  

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 26677-26686

MDPI

Access to resources Recommend Favorite

Up-Regulation of Urotensin II and Its Receptor Contributes to Human Hepatocellular Carcinoma Growth via Activation of the PKC, ERK1/2, and p38 MAPK Signaling Pathways

By Yu Xiao-Tong   Wang Peng-Yan   Shi Zheng-Ming   Dong Kun   Feng Ping   Wang Hong-Xia   Wang Xue-Jiang  

Molecules, Vol. 19, Iss. 12, 2014-12 ,pp. : 20768-20779

MDPI

Access to resources Recommend Favorite